This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Innovation in medical technology exists to improve patient outcomes, increase surgical efficiency and enhance patient safety. Infrequently, we see medical technology innovation of a paradigmatic nature that changes the way physicians approach disease states and dramatically improve results. So, again, innovation is great.
An international consensus statement on how to treat atrialfibrillation with catheter or surgical ablation has been published in EP Europace, a journal of the European Society of Cardiology (ESC), and was recently presented at EHRA 2024, a scientific congress held April 7-9 in Berlin, Germany.
The Heart Rhythm Society (HRS) is preparing for HRX 2024, the third annual event of its kind, which will be held from September 5-7, 2024, in Atlanta, GA, gathering cardiovascular health innovators together to explore discoveries and advance partnerships between medicine and technology. On Thursday, Sept. On Thursday, Sept.
The collaboration, according to a written statement issued by the company, aims to address challenges in capturing and analyzing cardiac signals to help physicians enhance patient outcomes for atrialfibrillation procedures. FDA 510(k) clearance and European CE Mark approval for its innovative products. adult population.
During its Annual Conference, HRS 2024, the Heart Rhythm Society (HRS) announced findings from three new studies demonstrating the safety and efficacy of pulsed field ablation (PFA), a nonthermal ablation treatment for patients with atrialfibrillation (AF). See full findings from the FARADISE, admIRE Study, and Advent Trial here.
Based on the results from the admIRE clinical trial, we are confident that this innovation has the promise to deliver significant value and differentiated capabilities, and become an important tool for the treatment of AFib." Global epidemiology of atrialfibrillation: An increasing epidemic and public health challenge.
We are thrilled to see the continuous innovation of our legacy Cryoablation portfolio alongside the approval of the PulseSelect PFA system in the U.S.," About AtrialFibrillation and Pulsed Field Ablation AF is one of the most common and undertreated heart rhythm disorders, affecting more than 60 million people worldwide3.
milla1cf Fri, 02/02/2024 - 17:18 February 2, 2024 — GE HealthCare (Nasdaq: GEHC) announces the latest innovation in electrophysiology (EP), the Prucka 3 with CardioLab EP Recording system, to help clinicians in the diagnosis and treatment of cardiac arrhythmias. The Increasing Role of Rhythm Control in Patients With AtrialFibrillation.
Introduction Atrialfibrillation (AF) is associated with a fivefold increased risk of stroke. Oral anticoagulation reduces the risk of stroke, but AF is elusive.
Bernard's Heart & Vascular Center , Jonesboro, Arkansas) mark a significant milestone in the pursuit of innovative solutions for non-valvular atrialfibrillation (NVAF) treatment. Atrialfibrillation ( AFib ) affects approximately 38 million patients globally, significantly increasing the risk of stroke1,2. The
Background Cryoballoon ablation (CBA) and laser balloon ablation (LBA) are two innovative ways for the treatment of atrialfibrillation (AF). This study aimed to evaluate the efficacy and safety of cryoballoon ablation and laser balloon ablation in patients with AF.
tim.hodson Wed, 03/12/2025 - 15:36 Broward Health recently announced it is now offering the Farapulse Pulsed Field Ablation System to treat atrialfibrillation (A-Fib). This innovative treatment represents a significant advancement over traditional thermal ablation methods and provides a more effective solution for patients.
Medtronic Creates History with FDA Approval of its Novel PulseSelect Pulsed Field Ablation System to Treat AtrialFibrillation 3. AtrialFibrillation Market Reaches $20.92B, According to New Report 9. Patients Implanted with Innovative FIRE1 Remote Heart Failure Monitoring System in Early Feasibility Study
cardiac electrophysiologist, performed one of the nations first procedures to control atrialfibrillation (Afib) using a new type of catheter that can deliver two different types of electrical energy or ablation to destroy the damaged part of the heart that is triggering the abnormal heartbeats. 12, 2025 On Feb.
25 include Efficacy and safety of finerenone across the spectrum of kidney risk in heart failure with mildly reduced or preserved ejection fraction during the session;"Innovations and Insights in Heart Failure With Preserved Ejection Fraction: Emerging Therapies, Biomarkers and Mechanistic Studies."
Clinical trials and innovative technology took center stage during the month of April, racking up some record number views. Shorten the Blanking Period After AtrialFibrillation Ablation, Experts Say 4. Here is a look at what DAIC viewers were reading last month: 1.
Titled "Real-world Data Affirms Safety and Effectiveness of Low/Zero Fluoroscopy AtrialFibrillation Ablation," the study was presented as a late-breaker at the 29th Annual International AF Symposium. Real-world Data Affirms Safety and Effectiveness of Low/Zero Fluoroscopy AtrialFibrillation Ablation [abstract].
AF Often Asymptomatic: Even for atrialfibrillation (AF)the most commonly symptomatic arrhythmiaover half of all cases were asymptomatic. Its estimated that undiagnosed atrialfibrillation alone costs the U.S. $3 Atrialfibrillation as an independent risk factor for stroke: The Framingham Study. 2016;11(8).
Background Catheter ablation (CA) for symptomatic atrialfibrillation (AF) offers the best outcomes for patients. We present real-world 5-year follow-up data of AI-guided pulmonary vein isolation.
BackgroundCatheter ablation is frequently used to manage recurrent atrialfibrillation (AF) resistant to drug therapy, with pulmonary vein isolation (PVI) as a key tactic.
Raj Makkar, MD, vice president of Cardiovascular Innovation and Intervention and the director of the Karsh Division of Interventional Cardiology in the Smidt Heart Institute at Cedars-Sinai, and his team of experts treat more than 10,000 patients every year.
Cryoablation (CRYO) is a novel catheter ablation technique for atrialfibrillation (AF). A study published in Cardiovascular Innovations and Applications explores whether CRYO influences the metabolic signature—a possibility not previously investigated.
Pulsed field ablation (PFA) is an innovative technology recently adopted for treating atrialfibrillation (AF). Preclinical and clinical studies have reported a reassuring safety profile because of its tissue-specific effect, sparing adjacent tissues.1
Left Atrial Appendage Occlusion (LAAO) procedures are done to reduce the risk of stroke in patients with atrialfibrillation by sealing off the left atrial appendage, preventing the formation of blood clots. and globally." We're honored to introduce our cardiology module in collaboration with the ACC.
Symptom-driven electrocardiogram (ECG) recording plays a significant role in the detection of post-ablation atrialfibrillation recurrence (AFR). The authors of an article published in Cardiovascular Innovations and Applications deployed a deep learning (DL)-based handheld device to facilitate symptom-driven monitoring.
Objective Risk-guided atrialfibrillation (AF) screening may be an opportunity to prevent adverse events in addition to stroke. The risk of AF was estimated using the FIND-AF (Future Innovations in Novel Detection of AtrialFibrillation) risk score.
28, 2025 At theAmerican College of Cardiology (ACC) 2025 meeting,GE HealthCare will introduce RevolutionVibe, i a new computed tomography (CT) system with Unlimited One-Beat Cardiac imaging to deliver consistent, high-quality images for patients, even in challenging cases like atrialfibrillation and heavily calcified coronaries.
Affecting 60 million people worldwide 1 , the prevalence of atrialfibrillation (AFib) is expected to increase by 60% by 2050 due to an aging population and rising cardiometabolic risk factors 2. In addition, the Centers for Disease Control and Prevention (CDC) estimates that more than 12 million Americans will have AFib by 2030 3.
A person’s LAA may create issues including atrialfibrillation and stroke. The LAA is a small pouch that extends from the side of the left atrium in the heart. Everyone has an LAA, but its size and anatomy vary. Medtronic launched the Penditure LAA Exclusion System in the U.S. on November 27. This technique is not widely available.
CardioFocus will feature its portfolio of innovative ablation systems which optimize lesion creation via confirmed tissue contact and sophisticated energy delivery. Our pursuit of innovation towards clinically meaningful ablation systems is driven by a focus on patient outcomes" said CardioFocus CEO Steve Ogilvie. "At
With the rise of digital health, innovative solutions are emerging that can significantly impact patient care and recovery while simultaneously addressing health equity. In 2020, she received the AHA/ASA David Sherman award for her lifetime contributions to post acute stroke care, research, training, innovation, and advocacy ([link] ).
CTA and the ACC recognize there is strong potential for cardiac monitoring (through Consumer Cardiovascular Technology Solutions) to help identify and screen patients with AtrialFibrillation (AFib) and related arrhythmias to alert the right clinical groups for early support and reduction in mortality rates.
The Dual Energy STSF Catheter is an exciting innovation because it allows customization of treatment by switching between radiofrequency and pulsed field energy,” said Dr. Andrea Natale, Executive Medical Director at Texas Cardiac Arrhythmia Institute at St.
milla1cf Thu, 01/18/2024 - 14:21 January 18, 2024 — Abbott announced the first global procedures have been conducted using the company's new Volt Pulsed Field Ablation (PFA) System to treat patients battling common abnormal heart rhythms such as atrialfibrillation (AFib). chief medical officer of Abbott's electrophysiology business.
With the addition of Shockwave, Johnson & Johnson will expand its MedTech cardiovascular portfolio into two of the highest-growth, innovation-oriented segments of cardiovascular intervention – coronary artery disease (CAD) and peripheral artery disease (PAD). It is currently undergoing clinical studies in the U.S.
With the increase of cardiovascular disease and shortage of sonographers around the globe, innovations like the Vscan Air SL with Caption AI are hugely transformative in cardiac care, supporting rapid and confident assessments at the point of care," said cardiologist Jordan B. Of these, approximately 30 are AI-enabled ultrasound innovations.
September is National AtrialFibrillation (AFib) Awareness Month, a time dedicated to raising awareness about one of the most common yet often misunderstood heart conditions. Understanding AtrialFibrillationAtrialFibrillation is characterized by an irregular and often rapid heart rhythm that can lead to poor blood flow.
a global leader in cardiac arrhythmia treatment and part of Johnson & Johnson MedTech , today announced European CE mark approval of the VARIPULSE Platform for the treatment of symptomatic drug refractory recurrent paroxysmal atrialfibrillation ( AF ) using pulsed field ablation (PFA). AtrialFibrillation. Circulation.
tim.hodson Wed, 03/12/2025 - 15:36 Broward Health recently announced it is now offering the Farapulse Pulsed Field Ablation System to treat atrialfibrillation (A-Fib). This innovative treatment represents a significant advancement over traditional thermal ablation methods and provides a more effective solution for patients.
September is National AtrialFibrillation (AFib) Awareness Month, a time dedicated to raising awareness about one of the most common yet often misunderstood heart conditions. Understanding AtrialFibrillationAtrialFibrillation is characterized by an irregular and often rapid heart rhythm that can lead to poor blood flow.
25 include Efficacy and safety of finerenone across the spectrum of kidney risk in heart failure with mildly reduced or preserved ejection fraction during the session;"Innovations and Insights in Heart Failure With Preserved Ejection Fraction: Emerging Therapies, Biomarkers and Mechanistic Studies."
Detection of Irregular Heart Rhythms Devices such as the Apple Watch or Fitbit Sense can detect irregular heart rhythms, including atrialfibrillation (AFib). By embracing this innovative approach, you can pave the way for a healthier heart and a brighter future.
These measurements can enable the early detection and monitoring of heart rhythm conditions such as atrialfibrillation. by opening a New York office, participating in the world renowned MedTech Innovator and by collaborating with renowned European and U.S. The FDA-clearance also allows FibriCheck to improve current U.S.
This announcement comes at a time when atrialfibrillation (AF) is on the rise, affecting more than 10.5 1 A growing patient population, increase in electrophysiology procedures, and rapid innovation in the field have led to elevated government scrutiny on cost, resulting in drastic cuts for reimbursement for common AF procedures.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content